This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Edwards Lifesciences LLC, a self-certified small disadvantaged business and limited liability company subsidiary of Edwards Lifesciences Corporation. The contract, with a ceiling value of $34,000.00, is for the provision of transcatheter aortic valve replacement (TAVR) products and related services to support healthcare services at VA facilities across the United States. The contract has an ultimate completion date of March 18, 2025. It is not associated with any set-aside designation. Edwards Lifesciences LLC has received numerous prime contract awards from the VA and Veterans Health Administration (VHA) to provide specialized cardiovascular devices and related services, including transcatheter heart valves, surgical implants, and prosthetics. The company also holds an active $1,590,000 Blanket Purchase Agreement with the VA-VHA to supply various Edwards valve products to the Veterans Integrated Service Network 21 through the end of 2028.
Generated 3/18/25, 10:00 AM